Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults
Status:
Terminated
Trial end date:
2020-01-21
Target enrollment:
Participant gender:
Summary
A Phase 2b Study to Determine the Efficacy of Candidate Influenza Vaccine MVA-NP+M1 in Adults
aged 18 years and over. To assess the effect of MVA-NP+M1 on the reduction of laboratory
confirmed influenza when given as an adjunct to licensed quadrivalent influenza vaccine (QIV)
in adults